Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pe van Dokkum

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Pharmacology|January 23, 2009
Possible new druggable targets for the treatment of nephrosis. Perhaps we should find them in caveolea?Richard Pe van Dokkum, Hendrik Buikema
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 12, 2011
Losartan protects mesenteric arteries from ROS-associated decrease in myogenic constriction following 5/6 nephrectomyPeter Vavrinec, Richard Pe van Dokkum, Maaike Goris, et al.
Journal of Hypertension|September 8, 2006
The role of angiotensin(1-7) in renal vasculature of the ratEls A van der Wouden, Peter Ochodnický, Richard Pe van Dokkum, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Pharmacology|January 23, 2009
Possible new druggable targets for the treatment of nephrosis. Perhaps we should find them in caveolea?Richard Pe van Dokkum, Hendrik Buikema
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 12, 2011
Losartan protects mesenteric arteries from ROS-associated decrease in myogenic constriction following 5/6 nephrectomyPeter Vavrinec, Richard Pe van Dokkum, Maaike Goris, et al.
Journal of Hypertension|September 8, 2006
The role of angiotensin(1-7) in renal vasculature of the ratEls A van der Wouden, Peter Ochodnický, Richard Pe van Dokkum, et al.
Pageof 1